About SpringRock Ventures
SpringRock Ventures is a venture capital firm founded in 2015. It is primarily based out of Seattle, United States. As of Jul 2026, SpringRock Ventures is an active investor, having invested in 60 companies, with 1 new investment in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to HealthTech and Life Sciences. Most recently it participated in the $***** Series A round of Karoo Health Overall, SpringRock Ventures portfolio has seen 5 IPOs and 16 acquisitions including key companies like Merck, Illumina and Johnson & Johnson. A lot of funds co-invest with SpringRock Ventures, with names like Triventures sharing a substantial percentage of its portfolio. SpringRock Ventures has team of 4 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 2 more
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
SpringRock Ventures' List of Top Investments
SpringRock Ventures has a portfolio of 60 companies. Their most notable investments are in Saykara and OFFOR Health.Their portfolio spans across United States, France and Israel. They have invested in Enterprise Applications, HealthTech, Life Sciences and 10 other sectors, across stages such as Series A, Seed and 2 more. Here is the list of top investments by SpringRock Ventures:1. Merck
Manufacturer of pharmaceutical products. The Company offers health solutions through its prescription medicines, vaccines, biological therapies, and animal health products, which it markets directly and through its joint ventures. It operates through one segment, Pharmaceutical. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. The Company has operations in the Pharmaceutical, Animal Health, Alliances, and Healthcare Services segments. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. As of August 2014, Merck's research and development efforts have led to the approval of more new drugs than any other company. Research performed at Merck has led to U.S. FDA approval of 63 New Molecular Entities. In 2022, the company recorded annual revenues of $57.09B and a net profit of $13.03B.
Key facts about Merck
- Founded Year: 1891
- Location: Rahway (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Employee Count: 44,751 as on Apr 30, 2026
- Investors: Berkshire Hathaway, Gershon Capital and 11 Others
- Latest Funding Round: Grant (prize money), Sep 15, 2021, $*****
- Highlight: Public
2. Illumina
Developer of technologies for analysis of genetic variation and function. The company provides laboratory instruments, kits, and reagents for research, drug development, and the development of molecular tests. The product categories include gene panel and array finder, microarray kits, clinical research, and IVD products.
Key facts about Illumina
- Founded Year: 1993
- Location: San Diego (United States)
- Stage: Public
- Total Funding till date: $28M
- Employee Count: 9,630 as on Sep 30, 2026
- Investors: Gershon Capital, Quan Funds and 32 Others
- Latest Funding Round: Grant (prize money), Jan 01, 2020, $*****
- Highlight: Public
Manufacturer, developer, and supplier of beauty care products, medical devices, and pharmaceutical products. The company working in medical devices are 3-D printing artificial joints personalized for each patient, while researchers in pharmaceuticals use AI to discover lifesaving drugs. It also pride on fostering healthy supplier relationships that are built on trust, transparency and unparalleled innovation, quality and reliability with an extended supply base comprising about 50,000 suppliers across our three business segments. In 2022, the company recorded annual revenues of $96.31B and a net profit of $12.72B.
Key facts about Johnson & Johnson
- Founded Year: 1886
- Location: New Brunswick (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Employee Count: 133,830 as on Sep 30, 2026
- Investors: Western Technology Investment, Alcor Fund and 17 Others
- Latest Funding Round: Conventional Debt, Feb 20, 2025, $*****
- Highlight: Public
Provider of health benefits for employees and individuals. It connects employers to a healthcare benefits provider and helps users plan their appointments, gather medical records, navigate post-op physical therapy, offer upfront bundled payments to employers, and more.
Key facts about Carrum Health
- Founded Year: 2013
- Location: San Mateo (United States)
- Stage: Series B
- Total Funding till date: $96M
- Employee Count: 301 as on Sep 30, 2026
- Investors: Cross Creek, Alchemist Accelerator and 8 Others
- Latest Funding Round: Series B, May 30, 2023, $*****
- Highlight: Editors' Pick
5. Hint Health
Provider of a SaaS-based practice management solution for healthcare professionals. The company has developed a software solution that assists healthcare providers with different administrative tasks such as medical billing, payment management, membership management, and more. The system has features for EHR software integration and automated workflow management.
Key facts about Hint Health
- Founded Year: 2013
- Location: San Francisco (United States)
- Stage: Series B
- Total Funding till date: $60.1M
- Employee Count: 86 as on Sep 30, 2026
- Investors: StartX, Webb Investment Network and 22 Others
- Latest Funding Round: Series B, Jun 01, 2022, $*****
- Highlight: Editors' Pick
SpringRock Ventures' Year-on-Year Investment Trends
SpringRock Ventures has invested in 60 companies over the last 10 years, with an average of 2 new investments annually in the last 10 years. In 2025, it made 3 investments, while as of Jul 2026, it has made 1 investment in this year. Its most recent first time investment was in Karoo Health and most recent follow-on round was in Vouched.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 2 | 1 | 3 |
2024 | 0 | 1 | 1 |
2023 | 2 | 3 | 5 |
2022 | 2 | 2 | 4 |
2021 | 4 | 3 | 7 |
2020 | 1 | 2 | 3 |
2019 | 1 | 0 | 1 |
2018 | 4 | 1 | 5 |
2017 | 2 | 0 | 2 |
SpringRock Ventures' Investments by Stage
SpringRock Ventures has made 11 investments in Series A stage with an average round size of $9.91M, 5 investments in Seed stage with an average round size of $5.35M, 3 investments in Series B stage with an average round size of $18.9M and 1 investment in Series C stage with an average round size of $24.5M.Stage of entry | No. of Investments |
|---|---|
Series A | 11 |
Seed | 5 |
Series B | 3 |
Series C | 1 |
Note: We have considered here, only first round of investments
SpringRock Ventures' Investments by Sector
SpringRock Ventures has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, Vertical SaaS, Healthcare and High Tech. Notably, it has invested in 44 Enterprise (B2B) companies, 43 Tech companies, 26 Software companies and at least 13 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 16 |
HealthTech | 14 |
Vertical SaaS | 6 |
Healthcare | 4 |
High Tech | 4 |
Others | 11 |
Note: We have considered here, only first round of investments
SpringRock Ventures' Investments by Geography
SpringRock Ventures has made most investments in United States (19), followed by Israel where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 19 |
Israel | 1 |
Note: We have considered here, only first round of investments
SpringRock Ventures' recent investments
SpringRock Ventures has made 1 investments in 2026 so far - Karoo Health.Here are the most recent investments by SpringRock Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jul 21, 2026 | United States | Series A | 2680 | [+3] | |
Sep 04, 2025 | United States | Series A | 9419 | ||
Feb 27, 2025 | United States | Seed | 4391 | ||
Feb 19, 2025 | United States | Series B | 5361 | [+4] | |
Oct 11, 2024 | United States | Series B | 1330 | [+3] |
IPOs and Publicly Listed companies in SpringRock Ventures' Portfolio
5 of SpringRock Ventures' portfolio companies have become public. Illumina got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jul 2000 at marketcap of undefined and Airspan got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $507M.Here are SpringRock Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 28, 2000 | - | - | 8382 | |
Jul 20, 2000 | - | - | 5797 | |
Jan 06, 1978 | - | - | 2438 | |
Apr 20, 1949 | - | - | 6103 | |
- | - | - | 1396 |
Acquired companies in SpringRock Ventures' Portfolio
16 companies from SpringRock Ventures' portfolio have been acquired. The most recent acquisition was OFFOR Health in Apr 2026 by Havencrest Capital Management for $*****.Here are SpringRock Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 09, 2026 | Jan 26, 2021 | Series A | 6916 | |
Jan 16, 2024 | - | - | 7275 | |
Jan 26, 2023 | Oct 18, 2018 | Seed | 1940 | |
Feb 08, 2021 | Jun 27, 2018 | Series A | 1983 | |
May 23, 2019 | - | - | 8345 |
Team profile of SpringRock Ventures
SpringRock Ventures has a team of 4 members including 1 Partner and 1 Venture Partner located in United States. SpringRock Ventures' team does not sit on the board of any company as of now.Co-investors of SpringRock Ventures
Over the past 10 years, 143 investors have co-invested in SpringRock Ventures's portfolio companies. This includes funds and angels.
- Invested before SpringRock Ventures: HHS, Point b and 39 others have invested in rounds before SpringRock Ventures. There are 2 companies where HHS has invested before SpringRock Ventures and 1 company where Point b has invested before SpringRock Ventures.
- Top Co-investors of SpringRock Ventures: 59 investors entered a company along with SpringRock Ventures. These include investors like Triventures (2 companies).
- Invested after SpringRock Ventures: A total of 43 investors have invested in SpringRock Ventures's portfolio after their investments. Top Investors include Revelation Partners (1 company), Tiger Global Management (1 company) and Cross Creek (1 company).
Recent News related to SpringRock Ventures
•
Vouched Secures $17M Series A for Expansion, Building on KYA Suite Successintelligence360•Sep 19, 2025•Vouched, SpringRock Ventures
•
Vouched Secures $17M for AI Agent Verification and KYA ToolsBiometricUpdate.com•Sep 04, 2025•BHG VC, Vouched, SpringRock Ventures, BHG Financial
•
Avandra raises $17.75 million to expand medical imaging data networkDOTmed•Mar 03, 2025•Avandra, Aegis Ventures, SpringRock Ventures, Memorial Hermann and 4 others
•
Charta Health Raises $8.1M in Seed FundingFinSMEs•Feb 27, 2025•Charta Health, Bain Capital Ventures, SV Angel, South Park Commons and 2 others
•
Health Systems Among Investors in Imaging Data Company AvandraHealthcare Innovation•Feb 19, 2025•Avandra Spa, Aegis Ventures, SpringRock Ventures, Memorial Hermann and 2 others
•
Avandra Raises $17.75M in FundingFinSMEs•Feb 19, 2025•Avandra Spa, Aegis, SpringRock Ventures, Memorial Hermann and 4 others
•
Avandra Launches with $17.75M to Create Largest Federated Network for De-Identified Medical Image DataHIT Consultant•Feb 17, 2025•Avandra, Aegis Ventures, SpringRock Ventures, Memorial Hermann and 4 others
•
Alpha Medical closes $24M Series B round to expand women’s telehealth — without the video callsTechCrunch+•Apr 23, 2024•Alpha, SpringRock Ventures
•
Proclaim Raises $15 Million So You Can Pressure Wash Your MouthFusoes & Aquisicoes•Jul 12, 2023•Proclaim, Khosla Ventures, Global Asset Capital, Ensemble Innovation Ventures and 2 others
•
DexCare raises $75M Series C led by ICONIQ Growth to match patients with the right healthcare providerTechStartups.com•Jun 21, 2023•DexCare, Iconiq Capital, Transformation Capital, Kaiser Permanente Ventures and 3 others
